[
  {
    "ts": null,
    "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of September 7",
    "summary": "A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read the full article here.",
    "url": "https://finnhub.io/api/news?id=ff914b676260c3d875ed7f5add1e0b873c78fd74eee4f340db91c840588fe9c1",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757099009,
      "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of September 7",
      "id": 136651455,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
      "related": "LDOS",
      "source": "SeekingAlpha",
      "summary": "A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read the full article here.",
      "url": "https://finnhub.io/api/news?id=ff914b676260c3d875ed7f5add1e0b873c78fd74eee4f340db91c840588fe9c1"
    }
  },
  {
    "ts": null,
    "headline": "Zacks.com featured highlights include Halozyme Therapeutics, Phibro, Leidos and PDD Holdings",
    "summary": "Halozyme, Phibro, Leidos and PDD Holdings shine as GARP picks, blending discounted valuations with strong long-term growth potential.",
    "url": "https://finnhub.io/api/news?id=a5b8e94bf9bc8021280adb2ca5bf12a823c5fb0cf50b940986a7f974eebb6d53",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757085420,
      "headline": "Zacks.com featured highlights include Halozyme Therapeutics, Phibro, Leidos and PDD Holdings",
      "id": 136653243,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LDOS",
      "source": "Yahoo",
      "summary": "Halozyme, Phibro, Leidos and PDD Holdings shine as GARP picks, blending discounted valuations with strong long-term growth potential.",
      "url": "https://finnhub.io/api/news?id=a5b8e94bf9bc8021280adb2ca5bf12a823c5fb0cf50b940986a7f974eebb6d53"
    }
  },
  {
    "ts": null,
    "headline": "Apple upgraded, AMD downgraded: Wall Street’s top analyst calls",
    "summary": "The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by The Fly. Top Upgrades: MoffettNathanson upgraded Apple (AAPL) to Neutral from Sell with a $225 price target. A number of key headwinds have faded and the “worst-case scenarios are off the table,” the firm tells investors. Evercore ISI upgraded Brinker (EAT) to Outperform from In Line with a price target of $210, up from $190.",
    "url": "https://finnhub.io/api/news?id=615f13692544b57246021e24ca8b2eeceeb890965218b26c23dc3548d85e2fed",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757082920,
      "headline": "Apple upgraded, AMD downgraded: Wall Street’s top analyst calls",
      "id": 136648835,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LDOS",
      "source": "Yahoo",
      "summary": "The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by The Fly. Top Upgrades: MoffettNathanson upgraded Apple (AAPL) to Neutral from Sell with a $225 price target. A number of key headwinds have faded and the “worst-case scenarios are off the table,” the firm tells investors. Evercore ISI upgraded Brinker (EAT) to Outperform from In Line with a price target of $210, up from $190.",
      "url": "https://finnhub.io/api/news?id=615f13692544b57246021e24ca8b2eeceeb890965218b26c23dc3548d85e2fed"
    }
  },
  {
    "ts": null,
    "headline": "Bet on These 3 Stocks With Upgraded Broker Ratings for Robust Returns",
    "summary": "Broker upgrades boost Halozyme, Leidos and TransUnion, each projected for solid 2025 earnings growth and stronger returns.",
    "url": "https://finnhub.io/api/news?id=1c91d1d69abe56034fe0327e5b6e6ab22fa69acc76429cb82309d166a0aeca0b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757081280,
      "headline": "Bet on These 3 Stocks With Upgraded Broker Ratings for Robust Returns",
      "id": 136648957,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LDOS",
      "source": "Yahoo",
      "summary": "Broker upgrades boost Halozyme, Leidos and TransUnion, each projected for solid 2025 earnings growth and stronger returns.",
      "url": "https://finnhub.io/api/news?id=1c91d1d69abe56034fe0327e5b6e6ab22fa69acc76429cb82309d166a0aeca0b"
    }
  }
]